首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Effects of Rhubarb combined with ulinastatin on T-cell subsets in sepsis rats
【24h】

Effects of Rhubarb combined with ulinastatin on T-cell subsets in sepsis rats

机译:大黄联合乌司他丁对败血症大鼠T细胞亚群的影响

获取原文
           

摘要

Objective: The pathogenesis of sepsis, a systemic inflammatory response syndrome, is very complicated and not well understood. However, the importance of lymphocyte percentage and ratio is implicated. Rhubarb is a traditional Chinese medication and plays a role in protecting gastrointestinal mucous and controlling the SIRS damage. Ulinastatin is a protease inhibitor that prevents overproduction of inflammatory cytokines. Currently, despite numerous sepsis clinical researches, the study on the effects of combined drug therapy on sepsis is lacking. In this study, we studied Rhubarb and Ulinastatin combination treatment on T lymphocyte subsets in sepsis induced by the cecal ligation and perforation (CLP). Immunosuppression happened at the early stage of severe sepsis in the CLP rat models, as CD3sup+/sup, CD4sup+/sup, CD4sup+/sup/CD8sup+/sup began to decline, dropped rapidly after 24 h and continuously decreased at 36 h. CD8sup+/sup T lymphocyte showed no significant change in all groups after CLP. The morality of CLP rats was increased with Rhubarb treatment in test dose (1.2 g/100 g). The immunosuppression state of CLP rats ameliorated with UTI treatment at early stage. The immunomodulatory properties were improved along with drug treatment, and immunities were obviously increased after 24 h, moreover, continuously increased at 36 h. The relief effect of immunosuppression after CLP showed much better in Rhubarb combined with UTI treatment than UTI monotherapy. In conclusion, the combination drug treatment facilitates the improvement of sepsis by modifying the lymphocyte percentage.
机译:目的:败血症是一种系统性的炎症反应综合征,其发病机理非常复杂,尚未得到很好的了解。然而,牵涉到淋巴细胞百分比和比率的重要性。大黄是传统中药,在保护胃肠道粘膜和控制SIRS损伤中发挥作用。乌司他丁是一种蛋白酶抑制剂,可防止炎症细胞因子的过度产生。目前,尽管进行了许多败血症临床研究,但是缺乏关于联合药物疗法对败血症的作用的研究。在这项研究中,我们研究了大黄和乌利他汀联合治疗盲肠结扎和穿孔(CLP)诱导的脓毒症T淋巴细胞亚群。在CLP大鼠模型中,免疫抑制发生在严重败血症的早期,如CD3 + ,CD4 + ,CD4 + / CD8 + 开始下降,在24小时后迅速下降,并在36小时后持续下降。 CLP后各组CD8 + T淋巴细胞均无明显变化。大黄治疗以试验剂量(1.2 g / 100 g)提高了CLP大鼠的道德。早期用UTI治疗可改善CLP大鼠的免疫抑制状态。随着药物处理,免疫调节特性得到改善,并且免疫力在24小时后明显增加,而且在36小时后持续增加。大黄联合UTI治疗后,CLP后免疫抑制的缓解效果明显优于单一疗法。总之,联合药物治疗通过改变淋巴细胞百分比来促进败血症的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号